EDGAR Filing Documents for 0001360865-14-000037

Form 8-K - Current report:

SEC Accession No. 0001360865-14-000037

Filing Date

2014-08-11

Accepted

2014-08-11 16:52:36

Documents

Period of Report

2014-08-11

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT ON FORM 8-K REPORTING CHANGE IN OPERATING BUSINESS OF THE ISSUER	petlife8kaugust112014.htm	8-K	181859
2	EXHIBIT 2.1. AGREEMENT AND PLAN OF MERGER DATED AS OF JUNE 26, 2014 BETWEEN ECO	exhibit21.htm	EX-2	13265
3	EXHIBIT 10.1. REORGANIZATION AGREEMENT DATED AS OF APRIL 28, 2014 BY AND BETWEEN	exhibit101.htm	EX-10	201863
4	EXHIBIT 10.2. PATENT LICENSE AGREEMENT DATED AS OF AUGUST 1, 2014 BETWEEN ARTHUR	exhibit102.htm	EX-10	50826
5	EXHIBIT 10.3. MANUFACTURING AGREEMENT DATED AS OF MAY 8, 2014 BETWEEN PETLIFE CO	exhibit103.htm	EX-10	5970
	Complete submission text file	0001360865-14-000037.txt		455542

Mailing Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210

Business Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210 (310) 279-5152

PetLife Pharmaceuticals, Inc. (Filer) CIK: 0001354591 (see all company filings)